Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hann-Chorng Kuo |
| Publication date | January 30, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |